Skip to main content
Log in

Hormonal changes in haemodialysed and in kidney-transplanted patients

  • Published:
International Urology and Nephrology Aims and scope Submit manuscript

Abstract

A total of 48 haemodialysed patients were studied by radioimmunoassay for the serum concentrations of parathormone, calcitonin, gastrin, insulin, prolactin, T3, T4, rT3, TSH and cortisol. Residual urines were measured for cAMP and ultrafiltrates for iPTH and gastrin. The duration of the dialysis programme, the number of haemodialysis sessions per week, sex distribution, the dialysis alternatives (including haemofiltration, haemoperfusion) and successful kidney transplantations were correlated with the serum hormone levels. Significant increases in PTH gastrin and prolactin values were demonstrated in the dialysed patients. However, their calcitonin and insulin concentrations decreased, parallel with the time elapsed since the start of the haemodialysis programme (HDP). The number of dialysis sessions per week was found to affect the hormone concentrations diversely. In the course of hemofiltration and haemoperfusion some of the centrations diversely. In the course of haemofiltration and haemoperfusion some of the hormone levels (e.g. PTH, gastrin) decreased significantly. The patients were in general euthyroid.

One of them, on HDP for several years, developed clinical and laboratory signs indicative of hyperthyroidism. In a considerable proportion of the cases the results of the hormone studies (increased PTH, CT, cAMP) were consistent with secondary hyperparathyroidism.

Kidney transplantation was followed by a decline of the serum prolactin, parathormone, calcitonin and aldosterone levels.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. Balogh, F., Petrányi, Gy., Rényi-Vámos, F.: Nephrologia. Medicina, Budapest 1980.

    Google Scholar 

  2. Beckett G. J., Henderson, C. J., Elwes, R., Seth, J., Lambie, A. T.: Thyroid status in the patients with chronic renal failure.Clin. Nephrol., 19, 172 (1983).

    PubMed  CAS  Google Scholar 

  3. Bonomini, V., Orsoni, I., Stefoni, S., Vangelista, A.: Hormonal changes in uremia.Clin. Nephrol., 11, 275 (1979).

    PubMed  CAS  Google Scholar 

  4. Cold, C. H., Morley, J. E., Viljoen, M., On Tim, L., De Fomseca M., Kalk, W. J.: Gastric acid secretion and serum gastrin levels in patients with chronic renal failure on regular hemodialysis.Nephron, 25, 92 (1980).

    Google Scholar 

  5. Christiensen, C. K., Nielsen, H. E., Brandsborg, M., Bradsborg, O.: Increased serum gastrin concentration in hemodialysis patients treated with 1-alfa-hydroxy vitamin D3.Scand. J. Gastroenterol., 12, 967 (1977).

    Article  Google Scholar 

  6. Cunningham, J., Segre, G. V., Statopolsky, E., Avioli, L. V.: Effect of histamin H2 receptor blockade on parathyroid status in normal and uraemic man.nephron, 38, 17 (1984).

    PubMed  CAS  Google Scholar 

  7. Giordano, C.: Thyroid function during hemodialysis and CAPD. 4th ISAP Off. Stat. Symp. on CAPD 1984, Cleveland, p. 535.

  8. Gurland, H. J., Castro, L. A., Samtleben, W., Fernandez, J. C.: Combination of hemodialysis and hemoperfusion in single unit for treatment of uremia.Clin. Nephrol., 11, 167 (1979).

    PubMed  CAS  Google Scholar 

  9. Hershman, J. M., Krugman, L. G., Kopple, J. D., Reef, A. W., Azukiwa, M., Shinaberger, J. H.: Thyroid function in patients on maintenance hemodialysis: unexplained low serum thyroxine concentration.Metabolism, XXVII, 755 (1978).

    Article  Google Scholar 

  10. Kokot, F.: the endocrine system in patients with acute renal failure.Proc. Eur. Dial. Transplant. Assoc., 18, 617 (1981).

    PubMed  CAS  Google Scholar 

  11. Kokot, F.: Endokrinologische Veränderungen bei der chronischen Niereninsuffizienz. In: R. Schmicker, P. T. Fröhling, K.-H. Götz (eds): Konservative Therapie der chronischen Niereninsuffizienz. II. Arbeitstagung der Gesellschaft für Nephrologie der DDR, Lindow/Mark 1982, p. 8.

  12. Kraiem, Z., Glaser, B., Rosenzweig, A., Scheinfeld, M., Ben-Ari, J.: A spot sample test for the estimation of urinary or nephrogenous, cAMP in the evaluation of parathyroid function.Nephron, 35, 264 (1983).

    PubMed  CAS  Google Scholar 

  13. Kramer, P., Matthaei, D., Fuchs, C., Arnold, R., Ebert, P., McIntosh, C., Schauder, P., Schwin, G., Scheler, F., Udwig, H., Reichel, J., Spitteller, S.: Assessment of hormone loss through hemofiltration.Trans. Am. Soc. Artif. Intern. Organs, 2, 128 (1978).

    Article  CAS  Google Scholar 

  14. Leusen, R., Neinders, A. E.: Cyclical changes in serum thyroid hormone concentrations related to hemodialysis: movement of hormone into and out of the extravascular space as a possible mechanism.Clin. Nephrol., 18, 193 (1982).

    PubMed  Google Scholar 

  15. Löcsey, L., Kakuk, Gy., Szabó, T., Wórum, I., Nagy, Z., Leövey, A.: Hormonal aspects and therapy of renal osteodystrophy.Orv. Hetil., 121, 2121 (1980).

    PubMed  Google Scholar 

  16. Löcsey, L., Lenkey, B., Kakuk, Gy., Leövey, A.: Hormonal changes in the course of the hemodialysis programme. Congress of the Association of Endocrinology and Metabolism, 7–10 October, 1984. Abstr. PS/VI-7.

  17. Ory, S. J.: Clinical uses of “luteinizing hormone releasing hormone”,Fertil. Steril., 39 577 (1983).

    PubMed  CAS  Google Scholar 

  18. Parathyroid hormones, calcium and vitamin D: In: F. H. Meyers, E. Jawetz, A. Glodfien (eds.): Lange Med. Publ., Los Altos, Calif. USA, 1980. Chapter 7, p. 369.

    Google Scholar 

  19. Quellhorst, E.: Folge erhöhter Elimination mittelmolekularer Substanzen: Depletion oder Regulation des Stoffwechsels. In: E. Streicher, W. Schoepe (eds): Die adaequate Dialyse. Springer Verlag, Berlin-Heidelberg-New York 1982, p. 201.

    Google Scholar 

  20. Schneider, H., Streicher, E., Hachmann, H., Chmiel, H., Mylius, U.: Clinical experience with hemofiltration.Proc. Eur. Dial. Transplant. Assoc. 14, 136 (1977).

    PubMed  CAS  Google Scholar 

  21. Sherwood, J., Reinhard, D., Garcia, M.: Does cimetidine inhibit parathyroid hormone secretion?N. Engl. J. Med., 300, 200 (1979).

    PubMed  CAS  Google Scholar 

  22. Szücs, J.: Human calcitonin, serum-phosphate, renal failure.Lancet, 1, 1108 (1974).

    Article  PubMed  Google Scholar 

  23. Szücs, J.: Calcitonin and uraemic bone dystrophy. Candidate's Thesis. Budapest 1977.

  24. Szücs, J., Makó, J., Fehér, T., Györgyi, T., Szathmári, M.: Serum-prolactin, testosterone, dehydroepiandrosterone sulphate in haemodialysis patients with chronic renal failure.Orv. Hetil., 125, 1865 (1984).

    PubMed  Google Scholar 

  25. Thysen, B., Gatz, M., Freeman, R., Alpert, B. E., Charytan, Ch.: Serum thyroid hormone levels in patients on continuous ambulatory peritoneal dialysis and regular hemodialysis.Nephron, 33, 49 (1983).

    PubMed  CAS  Google Scholar 

  26. Wagner, P. K., Krause, U., Scharfe, Th., Beyer, J., Rothmund, M.: Effect of cimetidine on basal and histamine-induced secretion of parathyroid hormone in vitro.Nephron, 36, 89 (1984).

    Article  PubMed  CAS  Google Scholar 

  27. Weissel, M., Stummvoll, H. K.: Serum reverse triiodothyronine (3,3′-5′α-Triiodothyronine) in end-stage renal failure.Nephron, 28, 303 (1981).

    PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Löcsey, L., Lenkey, Á. & Leövey, A. Hormonal changes in haemodialysed and in kidney-transplanted patients. International Urology and Nephrology 19, 201–213 (1987). https://doi.org/10.1007/BF02550474

Download citation

  • Received:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF02550474

Keywords

Navigation